CIK 0001832038 · <br>Emerging growth company
Invivyd, Inc.
Sign in to watch- Ticker
- IVVD
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 851403134
- Phone
- (781) 819-0080
- Business address
- 205 CHURCH STREET, NEW HAVEN, CT
- Former names
- Adagio Therapeutics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $177,089
- in 5 filings, $177K under 10b5-1 plans
Net −$177,089. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Andersen Jill −$53K Chief Legal Officer, Secretary sold 19% of stake
- Duke William E. −$32K Chief Financial Officer sold 19% of stake
- Green Julie −$32K Chief Human Resources Officer sold 19% of stake
- Lee Timothy Edward −$32K Chief Commercial Officer sold 19% of stake
- Allen Robert D. III −$29K Chief Scientific Officer sold 17% of stake
Reading 22 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-02-15 | Allen Robert D. III Chief Scientific Officer | Option exercise · Restricted Stock Units 10b5-1 | −99,000 | 102,000 | ||
| 2026-02-15 | Green Julie Chief Human Resources Officer | Option exercise 10b5-1 | +99,000 | 148,344 | ||
| 2026-02-15 | Green Julie Chief Human Resources Officer | Option exercise · Restricted Stock Units 10b5-1 | −99,000 | 102,000 | ||
| 2026-02-15 | Duke William E. Chief Financial Officer | Option exercise 10b5-1 | +99,000 | 148,344 | ||
| 2026-02-15 | Duke William E. Chief Financial Officer | Option exercise · Restricted Stock Units 10b5-1 | −99,000 | 102,000 | ||
| 2026-02-15 | Lee Timothy Edward Chief Commercial Officer | Option exercise 10b5-1 | +99,000 | 158,344 | ||
| 2026-02-15 | Lee Timothy Edward Chief Commercial Officer | Option exercise · Restricted Stock Units 10b5-1 | −99,000 | 102,000 | ||
| 2026-02-15 | Andersen Jill Chief Legal Officer, Secretary | Option exercise 10b5-1 | +165,000 | 249,446 | ||
| 2026-02-15 | Andersen Jill Chief Legal Officer, Secretary | Option exercise · Restricted Stock Units 10b5-1 | −165,000 | 170,000 | ||
| 2026-01-29 | Duke William E. Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +625,000 | 625,000 | ||
| 2026-01-29 | Green Julie Chief Human Resources Officer | Grant or award · Stock Option (Right to Buy) | +675,000 | 675,000 | ||
| 2026-01-29 | Lee Timothy Edward Chief Commercial Officer | Grant or award · Stock Option (Right to Buy) | +675,000 | 675,000 | ||
| 2026-01-29 | Andersen Jill Chief Legal Officer, Secretary | Grant or award · Stock Option (Right to Buy) | +820,000 | 820,000 | ||
| 2026-01-29 | Allen Robert D. III Chief Scientific Officer | Grant or award · Stock Option (Right to Buy) | +625,000 | 625,000 | ||
| 2025-11-19 | MCLAUGHLIN KEVIN F Director | Purchase | +50,000 | $2.50 | $125K | 50,000 |
| 2025-09-22 | BOLNO PAUL Director | Grant or award · Stock Option (Right to Buy) | +100,000 | 100,000 | ||
| 2025-08-19 | Lee Timothy Edward Chief Commercial Officer | Sale 10b5-1 | −29,643 | $0.57 | $17K | 59,344 |
| 2025-08-19 | Duke William E. Chief Financial Officer | Sale 10b5-1 | −29,643 | $0.57 | $17K | 49,344 |
| 2025-08-19 | Green Julie Chief Human Resources Officer | Sale 10b5-1 | −29,643 | $0.57 | $17K | 49,344 |
| 2025-08-19 | Andersen Jill Chief Legal Officer, Secretary | Sale 10b5-1 | −49,402 | $0.57 | $28K | 84,446 |
Page 3 of 9 · 161 trades